CD117 (c-KIT) staining in desmoplastic melanoma

Journal of Cutaneous Pathology

Volumn 38, Issue 9, 2011, Pages 753-755

  North, Jeffrey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

dermatopathology; desmoplastic malignant melanoma; immunoperoxidase; melanoma

Indexed keywords

STEM CELL FACTOR RECEPTOR;

FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MALE; MELANOMA; METABOLISM; PATHOLOGY; SKIN TUMOR; STAINING;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; PROTO-ONCOGENE PROTEINS C-KIT; SKIN NEOPLASMS; STAINING AND LABELING;

EID: 79960836122     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/j.1600-0560.2011.01730.x     Document Type: Letter

References (8)

1. Curtin JA, Busam K, Pinkel D, Bastian BC., Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340.
2. Nazarian RM, Prieto VG, Elder DE, Duncan LM., Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study. J Cutan Pathol 2010; 37 (Suppl. 1): 41.
3. Winnepenninckx V, De Vos R, Stas M., van den Oord JJ., New phenotypical and ultrastructural findings in spindle cell (desmoplastic/neurotropic) melanoma. Appl Immunohistochem Mol Morphol 2003; 11: 319.
4. Torres-Cabala CA, Wang WL, Trent J, et al., Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 2009; 22: 1446.
5. Kong Y, Si L, Zhu Y, et al., Large-scale analysis of KIT aberrations in chinese patients with melanoma. Clin Cancer Res 2011; 17: 1684.
6. Beadling C, Jacobson-Dunlop E, Hodi FS, et al., KIT gene mutations and copy number in melanoma subtypes. Clin Cancer Res 2008; 14: 6821.
7. Satzger I, Schaefer T, Kuettler U, et al., Analysis of c-KIT expression and KIT gene mutation in human mucosal melanomas. Br J Cancer 2008; 99: 2065.
8. Antonescu CR, Busam KJ, Francone TD, et al., L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer 2007; 121: 257.